Role of environment and sex differences in the development of autoimmune diseases: A roundtable meeting report

Journal of Women's Health

Volumn 22, Issue 7, 2013, Pages 578-586

  Mallampalli, Monica P ^a   Davies, Erika ^a   Wood, Debra ^a   Robertson, Hillary ^b   Polato, Federica ^a   Carter, Christine L ^a  

^a Society for Women's Health Research   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SEX HORMONE; TRICHLOROETHYLENE;

ARTICLE; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EPIGENETICS; FEMALE; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

AUTOIMMUNE DISEASES; ENVIRONMENTAL EXPOSURE; HUMANS; SEX FACTORS; UNITED STATES;

EID: 84880092684     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4462     Document Type: Article

References (70)

1. Miller FW, Alfredsson L, Costenbader KH, et al. Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 2012;39: 259-271.
2. Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008;173: 600-609.
3. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84: 223-243.
4. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33: 197-207.
5. Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000;90: 1463-1466.
6. NIH Autoimmune Diseases Coordinating Committee (ADCC). Progress in autoimmune diseases research: Report to Congress. Washington, DC: U.S. Department of Health and Human Services, 2005.
7. Costenbader KH, Gay S, Alarcon-Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases? Autoimmun Rev 2012;11: 604-609.
8. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009;33: 3-11.
9. Miller FW, Pollard KM, Parks CG, et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun 2012;39: 253-258.
10. Selmi C, Leung PS, Sherr DH, et al. Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun 2012;39: 272-284.
11. Germolec D, Kono DH, Pfau JC, Pollard KM. Animal models used to examine the role of the environment in the development of autoimmune disease: Findings from an NIEHS expert panel workshop. J Autoimmun 2012;39: 285-293.
12. Uramoto KM, Michet CJ, Jr., Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42: 46-50.
13. TEDDY Study Group. The environmental determinants of diabetes in the young (TEDDY) study. Ann N Y Acad Sci 2008;1150: 1-13.
14. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62: 1576-1582.
15. Pollard KM. Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 2012;38:J177-186.
16. Karlson EW, Chang SC, Cui J, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010;69: 54-60.
17. Cooper GS, Gilbert KM, Greidinger EL, et al. Recent advances and opportunities in research on lupus: Environmental influences and mechanisms of disease. Environ Health Perspect 2008;116: 695-702.
18. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmun Rev 2008;7: 626-630.
19. McNamara DM, Starling RC, Cooper LT, et al. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: Results of the IMAC (Intervention in myocarditis and acute cardiomyopathy)-2 study. J Am Coll Cardiol 2011;58: 1112-1118.
20. McCombe PA, Greer JM, Mackay IR. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009;9: 1058-1079.
21. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007;6: 366-372.
22. Lupus Foundation of America. How lupus differs in men. Available at: http://www.lupus.org/webmodules/webarticlesnet/templates/new-about.aspx? articleid=405&zoneid = 2.
23. Newland PK, Naismith RT, Ullione M. The impact of pain and other symptoms on quality of life in women with relapsing- remitting multiple sclerosis. J Neurosci Nurs 2009; 41: 322-328.
24. Guo ZN, He SY, Zhang HL, Wu J, Yang Y. Multiple sclerosis and sexual dysfunction. Asian J Androl 2012;14: 530-535.
25. Lateef A, Petri M. Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther 2012;14 Suppl 4:S4.
26. Miller FW. Environmental agents and autoimmune diseases. Adv Exp Med Biol 2011;711: 61-81.
27. Fernando MM, Stevens CR, Walsh EC, et al. Defining the role of the MHC in autoimmunity: A review and pooled analysis. PLoS Genet 2008;4:e1000024.
28. Okada Y, Yamada R, Suzuki A, et al. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1. Arthritis Rheum 2009;60: 3582-3590.
29. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012;38:J109-119.
30. Su DL, Lu ZM, Shen MN, Li X, Sun LY. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012;2012:347141.
31. Choubey D. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin Immunol 2012;142: 223-231.
32. Lateef A, Petri M. Hormone replacement and contraceptive therapy in autoimmune diseases. J Autoimmun 2012;38: J170-176.
33. Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012;64: 2319-2327.
34. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007;29: 1-9.
35. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two casecontrol studies. BMJ 2000;321: 323-329.
36. Parks CG, Cooper GS, Nylander-French LA, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum 2002;46: 1840-1850.
37. Gold LS, Ward MH, Dosemeci M, De Roos AJ. Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 2007;56: 3189-3201.
38. Olsson AR, Skogh T, Axelson O, Wingren G. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup Environ Med 2004;61: 233-238.
39. Khuder SA, Peshimam AZ, Agraharam S. Environmental risk factors for rheumatoid arthritis. Rev Environ Health 2002;17: 307-315.
40. Coble J, Hoppin JA, Engel L, et al. Prevalence of exposure to solvents, metals, grain dust, and other hazards among farmers in the Agricultural Health Study. J Expo Anal Environ Epidemiol 2002;12: 418-426.
41. Parks CG, Walitt BT, Pettinger M, et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken) 2011;63: 184-194.
42. Parks CG, D'Aloisio AA, DeRoo LA, et al. Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood. Ann Rheum Dis 2013;72: 350-356.
43. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol 2012;13: 333-332.
44. Rozzo SJ, Allard JD, Choubey D, et al. Evidence for an interferon- inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001;15: 435-443.
45. Jorgensen TN, Roper E, Thurman JM, Marrack P, Kotzin BL. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun 2007;8: 653-662.
46. Panchanathan R, Shen H, Bupp MG, Gould KA, Choubey D. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol 2009;183: 7031-7038.
47. Panchanathan R, Duan X, Arumugam M, Shen H, Liu H, Choubey D. Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Mol Immunol 2011;49: 273-280.
48. Choubey D, Panchanathan R, Duan X, Liu H. Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. J Interferon Cytokine Res 2011;31: 893-906.
49. Panchanathan R, Liu H, Fang CM, Erickson LD, Pitha PM, Choubey D. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J Immunol 2012;188: 270-278.
50. Shen H, Panchanathan R, Rajavelu P, Duan X, Gould KA, Choubey D. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J Mol Cell Biol 2010;2: 284-290.
51. Richardson B. Primer. Epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007;3: 521-527.
52. Patel DR, Richardson BC. Dissecting complex epigenetic alterations in human lupus. Arthritis Res Ther 2013;15:201.
53. Hewagama A, Gorelik G, Patel D, et al. Overexpression of XLinked genes in T cells from women with lupus. J Autoimmun 2013;41: 60-71.
54. Sawalha AH, Wang L, Nadig A, et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J Autoimmun 2012;38:J216-222.
55. Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008;58: 1001-1009.
56. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008;10:R101.
57. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011;157: 163-179.
58. Ceribelli A, Yao B, Dominguez-Gutierrez PR, Nahid MA, Satoh M, Chan EK. MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther 2011;13:229.
59. Ceribelli A, Satoh M, Chan EK. MicroRNAs and autoimmunity. Curr Opin Immunol 2012;24: 686-691.
60. Dai R, Zhang Y, Khan D, et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One. 2010; 5:e14302.
61. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: A novel mechanism of immune modulation. Blood 2008;112: 4591-4597.
62. Singh NP, Singh UP, Guan H, Nagarkatti P, Nagarkatti M. Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression. PLoS One 2012;7:e45054.
63. Fisher MT, Nagarkatti M, Nagarkatti PS. 2,3,7,8-tetrachlorodibenzo- p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol Pharmacol 2005;67: 327-335.
64. Singh NP, Singh UP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One 2011;6:e23522.
65. Griffin JM, Gilbert KM, Lamps LW, Pumford NR. CD4( +) Tcell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+ / + mice. Toxicol Sci 2000;57: 345-352.
66. Fernandes Azevedo B, Barros Furieri L, Pecanha FM, et al. Toxic effects of mercury on the cardiovascular and central nervous systems. J Biomed Biotechnol 2012;2012: 949048.
67. Caldas ED, Jardim AN. Exposure to toxic chemicals in the diet: Is the Brazilian population at risk? J Expo Sci Environ Epidemiol 2011;22: 1-15.
68. Chan TY. Inorganic mercury poisoning associated with skinlightening cosmetic products. Clin Toxicol (Phila) 2011;49: 886-891.
69. Eisler R. Mercury hazards from gold mining to humans, plants, and animals. Rev Environ Contam Toxicol 2004;181: 139-198.
70. Gardner RM, Nyland JF, Silva IA, Ventura AM, de Souza JM, Silbergeld EK. Mercury exposure, serum antinuclear/ antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: A cross-sectional study. Environ Res 2010;110: 345-354.